vs

Side-by-side financial comparison of ALKAMI TECHNOLOGY, INC. (ALKT) and CROSS COUNTRY HEALTHCARE INC (CCRN). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $126.1M, roughly 1.9× ALKAMI TECHNOLOGY, INC.). ALKAMI TECHNOLOGY, INC. runs the higher net margin — -7.9% vs -35.0%, a 27.1% gap on every dollar of revenue. On growth, ALKAMI TECHNOLOGY, INC. posted the faster year-over-year revenue change (28.9% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $-7.4M). Over the past eight quarters, ALKAMI TECHNOLOGY, INC.'s revenue compounded faster (23.9% CAGR vs -21.0%).

Alkami Technology, Inc. delivers cloud-native digital banking platforms and supporting solutions for US financial institutions. Its offerings include online and mobile banking interfaces, payment processing tools, data analytics modules, and customer engagement functionalities, primarily serving community banks and credit unions to enhance their customers' digital banking experiences.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

ALKT vs CCRN — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.9× larger
CCRN
$236.8M
$126.1M
ALKT
Growing faster (revenue YoY)
ALKT
ALKT
+52.5% gap
ALKT
28.9%
-23.6%
CCRN
Higher net margin
ALKT
ALKT
27.1% more per $
ALKT
-7.9%
-35.0%
CCRN
More free cash flow
CCRN
CCRN
$23.5M more FCF
CCRN
$16.1M
$-7.4M
ALKT
Faster 2-yr revenue CAGR
ALKT
ALKT
Annualised
ALKT
23.9%
-21.0%
CCRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALKT
ALKT
CCRN
CCRN
Revenue
$126.1M
$236.8M
Net Profit
$-10.0M
$-82.9M
Gross Margin
58.6%
Operating Margin
36.9%
-30.2%
Net Margin
-7.9%
-35.0%
Revenue YoY
28.9%
-23.6%
Net Profit YoY
-27.5%
-2109.7%
EPS (diluted)
$-2.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALKT
ALKT
CCRN
CCRN
Q1 26
$126.1M
Q4 25
$120.8M
$236.8M
Q3 25
$113.0M
$250.1M
Q2 25
$112.1M
$274.1M
Q1 25
$97.8M
$293.4M
Q4 24
$89.7M
$309.9M
Q3 24
$85.9M
$315.1M
Q2 24
$82.2M
$339.8M
Net Profit
ALKT
ALKT
CCRN
CCRN
Q1 26
$-10.0M
Q4 25
$-82.9M
Q3 25
$-14.8M
$-4.8M
Q2 25
$-13.6M
$-6.7M
Q1 25
$-490.0K
Q4 24
$-3.8M
Q3 24
$-9.4M
$2.6M
Q2 24
$-12.3M
$-16.1M
Gross Margin
ALKT
ALKT
CCRN
CCRN
Q1 26
58.6%
Q4 25
57.2%
Q3 25
56.8%
20.4%
Q2 25
58.6%
20.4%
Q1 25
59.0%
20.0%
Q4 24
59.3%
Q3 24
58.9%
20.4%
Q2 24
59.4%
20.8%
Operating Margin
ALKT
ALKT
CCRN
CCRN
Q1 26
36.9%
Q4 25
-7.9%
-30.2%
Q3 25
-11.4%
-2.4%
Q2 25
-14.2%
-2.1%
Q1 25
-15.7%
-0.3%
Q4 24
-9.6%
-1.1%
Q3 24
-12.1%
0.9%
Q2 24
-16.1%
-5.7%
Net Margin
ALKT
ALKT
CCRN
CCRN
Q1 26
-7.9%
Q4 25
-35.0%
Q3 25
-13.1%
-1.9%
Q2 25
-12.1%
-2.4%
Q1 25
-0.2%
Q4 24
-1.2%
Q3 24
-11.0%
0.8%
Q2 24
-15.0%
-4.7%
EPS (diluted)
ALKT
ALKT
CCRN
CCRN
Q1 26
Q4 25
$-0.11
$-2.56
Q3 25
$-0.14
$-0.15
Q2 25
$-0.13
$-0.20
Q1 25
$-0.08
$-0.02
Q4 24
$-0.07
$-0.13
Q3 24
$-0.09
$0.08
Q2 24
$-0.13
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALKT
ALKT
CCRN
CCRN
Cash + ST InvestmentsLiquidity on hand
$40.4M
$108.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$370.7M
$322.8M
Total Assets
$829.3M
$449.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALKT
ALKT
CCRN
CCRN
Q1 26
$40.4M
Q4 25
$63.5M
$108.7M
Q3 25
$57.3M
$99.1M
Q2 25
$52.4M
$81.2M
Q1 25
$61.7M
$80.7M
Q4 24
$94.4M
$81.6M
Q3 24
$81.0M
$64.0M
Q2 24
$61.4M
$69.6M
Stockholders' Equity
ALKT
ALKT
CCRN
CCRN
Q1 26
$370.7M
Q4 25
$362.0M
$322.8M
Q3 25
$350.1M
$408.1M
Q2 25
$344.0M
$412.2M
Q1 25
$334.0M
$418.2M
Q4 24
$357.0M
$419.0M
Q3 24
$338.5M
$424.7M
Q2 24
$327.2M
$433.3M
Total Assets
ALKT
ALKT
CCRN
CCRN
Q1 26
$829.3M
Q4 25
$847.2M
$449.0M
Q3 25
$835.2M
$538.2M
Q2 25
$840.4M
$553.8M
Q1 25
$837.2M
$576.2M
Q4 24
$437.3M
$589.3M
Q3 24
$422.2M
$597.4M
Q2 24
$403.9M
$602.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALKT
ALKT
CCRN
CCRN
Operating Cash FlowLast quarter
$-4.8M
$18.2M
Free Cash FlowOCF − Capex
$-7.4M
$16.1M
FCF MarginFCF / Revenue
-5.8%
6.8%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$40.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALKT
ALKT
CCRN
CCRN
Q1 26
$-4.8M
Q4 25
$16.6M
$18.2M
Q3 25
$30.8M
$20.1M
Q2 25
$1.2M
$4.2M
Q1 25
$-5.7M
$5.7M
Q4 24
$6.1M
$24.2M
Q3 24
$11.0M
$7.5M
Q2 24
$548.0K
$82.4M
Free Cash Flow
ALKT
ALKT
CCRN
CCRN
Q1 26
$-7.4M
Q4 25
$16.2M
$16.1M
Q3 25
$30.5M
$17.9M
Q2 25
$760.0K
$2.3M
Q1 25
$-6.1M
$3.8M
Q4 24
$6.0M
$21.7M
Q3 24
$10.7M
$6.3M
Q2 24
$123.0K
$79.6M
FCF Margin
ALKT
ALKT
CCRN
CCRN
Q1 26
-5.8%
Q4 25
13.4%
6.8%
Q3 25
27.0%
7.2%
Q2 25
0.7%
0.8%
Q1 25
-6.3%
1.3%
Q4 24
6.6%
7.0%
Q3 24
12.4%
2.0%
Q2 24
0.1%
23.4%
Capex Intensity
ALKT
ALKT
CCRN
CCRN
Q1 26
Q4 25
0.3%
0.9%
Q3 25
0.2%
0.9%
Q2 25
0.4%
0.7%
Q1 25
0.5%
0.6%
Q4 24
0.2%
0.8%
Q3 24
0.4%
0.4%
Q2 24
0.5%
0.8%
Cash Conversion
ALKT
ALKT
CCRN
CCRN
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.92×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALKT
ALKT

Segment breakdown not available.

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

Related Comparisons